Treat or Refer? Improving the Management of Atopic Dermatitis in the Primary Care Setting
Upon completion of this activity, learners will be able to:
- Review the prevalence, incidence, and risk factors of AD
- Discuss the differential diagnosis of AD across diverse patients
- Introduce clinical practices to ensure that patients with AD are receiving timely and optimal treatment
Speakers’ Bureau: Abbvie, Eli Lilly, Leo Pharma, Pfizer, Regeneron, Sanofi-Genzyme
Discussion of Off-Label, Investigational, or Experimental Drug/Device Use: None
The Academy for Continued Healthcare Learning is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The Academy for Continued Healthcare Learning designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Physician assistants, nurse practitioners, and nurses may participate in this educational activity and earn a certificate of completion as AAPA, AANP, and ANCC accept AMA PRA Category 1 Credits™ through their reciprocity agreements.